| Literature DB >> 29133313 |
Katrien Vanthomme1, Laura Van den Borre1, Hadewijch Vandenheede1, Paulien Hagedoorn1, Sylvie Gadeyne1.
Abstract
OBJECTIVE: This study probes into site-specific cancer mortality inequalities by employment and occupational group among Belgians, adjusted for other indicators of socioeconomic (SE) position.Entities:
Keywords: cancer mortality; occupational status; socioeconomic inequalities
Mesh:
Year: 2017 PMID: 29133313 PMCID: PMC5695485 DOI: 10.1136/bmjopen-2016-015216
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Cancer sites by ICD-10 classification and level of preventability
| ICD-10* | Preventable | ||
| Men | Women | ||
| Malignant neoplasms of: | |||
| Head and neck | C00–C14, C30–C32 | Yes | – |
| Oesophagus | C15 | Yes | Yes |
| Stomach | C16 | Yes | No |
| Colorectum and anus | C18–C21 | Yes | Yes |
| Liver | C22 | Yes | No |
| Pancreas | C25 | No | No |
| Lung, bronchus and trachea | C33–C34 | Yes | Yes |
| Breast | C50 | – | Yes |
| Cervix uteri | C53 | – | Yes |
| Uterus | C54–C55 | – | Yes |
| Ovary | C56 | – | No |
| Prostate | C61 | Yes | – |
| Kidney | C64–C66, C68 | No | No |
| Bladder | C67 | Yes | Yes |
| Eye, brain and central nervous system | C69–C72 | No | No |
| Malignant melanoma | C43–C44 | Yes | Yes |
| Non-Hodgkin’s lymphoma | C82–C85 | No | No |
| Multiple myeloma | C90 | No | No |
| Leukaemia | C91–C95 | No | No |
The empty cells are cancer sites not included for either men or women.
* International Classification of Diseases and Related Health Problems - Tenth Revision
Description of the study population
| ISCO* | Occupational status | Men | Women | ||
| Population | Cancer deaths | Population | Cancer deaths | ||
| Disabled | 37 286 | 2235 | 26 905 | 824 | |
| Unemployed and not looking for a job | 295 674 | 21 704 | 924 226 | 25 953 | |
| Employed and looking for a job | 121 757 | 4418 | 235 766 | 2931 | |
| Employed | 1 776 668 | 34 732 | 1 146 582 | 11 943 | |
| 1–2 | Managers and professionals | 452 268 | 8529 | 339 663 | 3512 |
| 3–4 | Intermediate white-collar workers | 432 803 | 8114 | 384 478 | 3761 |
| 5 | Service and sales workers | 92 369 | 1837 | 167 625 | 1670 |
| 6 | Agricultural and fishery workers | 52 529 | 1352 | 17 303 | 282 |
| 7–8 | Skilled manual workers | 556 418 | 10 990 | 87 631 | 858 |
| 9 | Unskilled manual workers | 163 433 | 3560 | 147 887 | 1848 |
| Missing | 26 848 | 350 | 1995 | 12 | |
* International Standard Classification of Occupations.
Absolute site-specific cancer mortality rates (and 95% CI) (2001–2011) among the Belgian population within the economically active age range, by employment group in 1991
| Men | Employed | Unemployed and looking for a job | Unemployed and not looking for a job | Disabled |
| All cancers | 256.9 (253.8 to 260.0) | 436.4 (423.0 to 449.9) | 380.2 (368.6 to 391.9) | 484.3 (462.7 to 506.0) |
| Preventable cancers | ||||
| Head and neck | 11.7 (11.2 to 12.3) | 38.6 (34.7 to 42.4) | 24.8 (20.8 to 28.7) | 31.3 (25.0 to 37.6) |
| Oesophagus | 10.3 (9.7 to 10.9) | 20.9 (18.0 to 23.7) | 12.8 (10.4 to 15.2) | 15.9 (11.9 to 19.9) |
| Stomach | 8.2 (7.7 to 8.8) | 11.9 (9.7 to 14.2) | 14.5 (12.0 to 17.0) | 17.0 (12.9 to 21.0) |
| Colorectal | 25.8 (24.8 to 26.8) | 30.4 (26.8 to 34.0) | 34.3 (30.9 to 37.6) | 33.3 (27.9 to 38.8) |
| Liver | 7.8 (7.2 to 8.3) | 12.5 (10.3 to 14.7) | 10.8 (8.6 to 13.0) | 13.5 (9.8 to 17.3) |
| Lung | 88.8 (87.0 to 90.6) | 173.1 (164.6 to 181.7) | 148.8 (141.6 to 156.0) | 195.0 (181.6 to 208.3) |
| Prostate | 17.2 (16.3 to 18.1) | 17.3 (14.4 to 20.2) | 19.1 (17.6 to 20.6) | 27.9 (23.3 to 32.4) |
| Bladder | 8.1 (7.5 to 8.7) | 14.5 (12.0 to 17.1) | 11.8 (10.3 to 13.4) | 19.5 (15.2 to 23.8) |
| Malignant melanoma | 3.0 (2.7 to 3.3) | 3.4 (2.2 to 4.5) | 1.9 (1.2 to 2.6) | 3.3 (1.2 to 5.3) |
| Non-preventable cancers | ||||
| Pancreas | 13.5 (12.8 to 14.3) | 18.3 (15.5 to 21.1) | 15.4 (13.3 to 17.4) | 21.3 (16.5 to 26.1) |
| Kidney | 7.8 (7.2 to 8.3) | 8.1 (6.3 to 10.0) | 9.0 (7.3 to 10.8) | 12.2 (8.8 to 15.7) |
| Eye, nervous system | 7.3 (6.8 to 7.8) | 6.9 (5.3 to 8.5) | 8.1 (6.2 to 10.1) | 10.4 (7.0 to 13.9) |
| Non-Hodgkin | 6.2 (5.7 to 6.7) | 8.4 (6.5 to 10.3) | 6.9 (5.5 to 8.3) | 10.1 (6.7 to 13.5) |
| Multiple myeloma | 3.8 (3.4 to 4.2) | 3.5 (2.3 to 4.6) | 4.0 (3.1 to 4.9) | 4.5 (2.4 to 6.6) |
| Leukaemia | 7.6 (7.0 to 8.2) | 8.6 (6.6 to 10.6) | 10.1 (8.4 to 11.8) | 9.2 (6.4 to 12.0) |
| Cancer deaths | 164.7 (160.0 to 169.4) | 200.2 (181.6 to 218.9) | 187.5 (184.8 to 190.3) | 312.4 (286.7 to 338.1) |
| Preventable cancers | ||||
| Oesophagus | 3.3 (2.5 to 4.0) | 3.0 (2.2 to 3.9) | 2.8 (2.5 to 3.1) | 4.7 (2.0 to 7.3) |
| Colorectal | 15.4 (14.0 to 16.8) | 16.3 (11.6 to 20.9) | 18.5 (17.7 to 19.2) | 35.7 (26.6 to 44.7) |
| Lung | 23.9 (22.2 to 25.7) | 40.4 (31.6 to 49.3) | 28.7 (27.6 to 29.9) | 51.5 (41.1 to 61.9) |
| Breast | 41.0 (38.8 to 43.1) | 40.7 (33.4 to 47.9) | 42.4 (41.0 to 43.8) | 70.8 (58.3 to 83.3) |
| Cervix | 2.8 (2.2 to 3.3) | 7.3 (2.9 to 11.6) | 3.9 (3.4 to 4.4) | 3.8 (0.7 to 6.9) |
| Uterus | 5.6 (4.6 to 6.6) | 5.0 (3.9 to 6.1) | 6.1 (5.6 to 6.5) | 7.4 (3.9 to 10.9) |
| Bladder | 1.6 (1.2 to 2.1) | 2.9 (0.0 to 6.0) | 2.5 (2.2 to 2.8) | 7.6 (3.4 to 11.7) |
| Malignant melanoma | 2.5 (2.0 to 2.9) | 3.8 (0.7 to 6.9) | 2.3 (2.0 to 2.6) | 1.9 (0.3 to 3.9) |
| Non-preventable cancers | ||||
| Stomach | 3.2 (2.6 to 3.9) | 4.4 (1.3 to 7.5) | 4.4 (4.0 to 4.8) | 9.8 (4.7 to 14.8) |
| Liver | 2.9 (2.3 to 3.5) | 5.6 (1.3 to 9.9) | 4.6 (4.2 to 5.0) | 6.1 (2.7 to 9.5) |
| Pancreas | 10.4(9.0 to 11.7) | 8.3 (5.0 to 11.5) | 10.9 (10.3 to 11.5) | 14.5 (9.1 to 19.9) |
| Ovary | 13.4 (12.0 to 14.7) | 9.0 (7.6 to 10.5) | 12.4 (11.7 to 13.1) | 13.2 (8.1 to 18.3) |
| Kidney | 2.8 (2.2 to 3.4) | 5.8 (1.4 to 10.1) | 4.3 (3.9 to 4.7) | 6.8 (3.9 to 9.7) |
| Eye, nervous system | 5.3 (4.5 to 6.1) | 5.4 (2.3 to 8.5) | 5.7 (5.2 to 6.3) | 11.1 (6.2 to 16.0) |
| Non-Hodgkin | 3.9 (3.1 to 4.7) | 4.6 (1.5 to 7.8) | 4.6 (4.2 to 5.0) | 7.2 (2.7 to 11.8) |
| Multiple myeloma | 2.7 (2.0 to 3.4) | 3.2 (0.1 to 6.3) | 3.3 (2.9 to 3.6) | 2.1 (0.2 to 4.0) |
| Leukaemia | 5.0 (4.1 to 5.9) | 2.6 (1.8 to 3.4) | 5.3 (4.9 to 5.7) | 8.7 (3.9 to 13.6) |
Net relative site-specific cancer mortality inequality (mortality rate ratios and 95% CI) (2001–2011) among the Belgian population within the economically active age range, by employment group in 1991
| Men | Employed | Unemployed and looking for a job | Unemployed and not looking for a job | Disabled | |||
| All cancers | 1.00 | 1.60 | 1.55 to 1.65 | 2.74 | 2.69 to 2.80 | 2.28 | 2.19 to 2.37 |
| Preventable cancers | |||||||
| Head and neck | 1.00 | 2.33 | 2.10 to 2.59 | 2.73 | 2.46 to 3.02 | 2.18 | 1.80 to 2.65 |
| Oesophagus | 1.00 | 2.09 | 1.83 to 2.38 | 2.36 | 2.12 to 2.62 | 1.98 | 1.59 to 2.48 |
| Stomach | 1.00 | 1.35 | 1.13 to 1.61 | 2.97 | 2.68 to 3.30 | 2.65 | 2.15 to 3.28 |
| Colorectal | 1.00 | 1.26 | 1.14 to 1.41 | 2.61 | 2.45 to 2.77 | 1.71 | 1.48 to 1.99 |
| Liver | 1.00 | 1.49 | 1.25 to 1.76 | 2.31 | 2.06 to 2.60 | 2.29 | 1.82 to 2.88 |
| Lung | 1.00 | 1.71 | 1.63 to 1.79 | 2.86 | 2.77 to 2.95 | 2.52 | 2.37 to 2.69 |
| Prostate | 1.00 | 1.17 | 1.01 to 1.35 | 2.78 | 2.59 to 2.99 | 2.30 | 1.96 to 2.70 |
| Bladder | 1.00 | 1.91 | 1.62 to 2.25 | 3.37 | 3.05 to 3.73 | 2.65 | 2.13 to 3.29 |
| Malignant melanoma | 1.00 | 1.30 | 0.97 to 1.73 | 1.90 | 1.57 to 2.31 | 1.05 | 0.59 to 1.88 |
| Non-preventable cancers | |||||||
| Pancreas | 1.00 | 1.38 | 1.21 to 1.58 | 2.44 | 2.24 to 2.66 | 1.85 | 1.53 to 2.25 |
| Kidney | 1.00 | 1.18 | 0.97 to 1.45 | 2.39 | 2.14 to 2.68 | 2.52 | 2.01 to 3.16 |
| Eye, nervous system | 1.00 | 0.94 | 0.75 to 1.17 | 2.14 | 1.88 to 2.44 | 2.15 | 1.64 to 2.82 |
| Non-Hodgkin | 1.00 | 1.35 | 1.09 to 1.66 | 2.42 | 2.13 to 2.75 | 1.79 | 1.33 to 2.43 |
| Multiple myeloma | 1.00 | 1.25 | 0.93 to 1.68 | 2.86 | 2.46 to 3.32 | 1.48 | 0.97 to 2.25 |
| Leukaemia | 1.00 | 1.05 | 0.84 to 1.31 | 2.73 | 2.44 to 3.06 | 1.72 | 1.30 to 2.28 |
| Cancer deaths | 1.00 | 1.11 | 1.07 to 1.15 | 1.74 | 1.71 to 1.78 | 1.96 | 1.83 to 2.09 |
| Preventable cancers | |||||||
| Oesophagus | 1.00 | 1.35 | 1.04 to 1.75 | 1.67 | 1.40 to 1.99 | 1.94 | 1.15 to 3.26 |
| Colorectal | 1.00 | 1.09 | 0.97 to 1.23 | 1.79 | 1.68 to 1.92 | 2.23 | 1.83 to 2.73 |
| Lung | 1.00 | 1.19 | 1.10 to 1.29 | 1.61 | 1.53 to 1.70 | 1.82 | 1.54 to 2.14 |
| Breast | 1.00 | 1.02 | 0.95 to 1.09 | 1.64 | 1.57 to 1.71 | 1.93 | 1.68 to 2.22 |
| Cervix | 1.00 | 1.78 | 1.45 to 2.18 | 1.85 | 1.57 to 2.19 | 0.90 | 0.42 to 1.91 |
| Uterus | 1.00 | 1.36 | 1.11 to 1.67 | 2.12 | 1.86 to 2.40 | 1.83 | 1.22 to 2.75 |
| Bladder | 1.00 | 1.07 | 0.73 to 1.56 | 1.99 | 1.63 to 2.43 | 3.20 | 1.92 to 5.34 |
| Malignant melanoma | 1.00 | 1.02 | 0.79 to 1.32 | 1.35 | 1.14 to 1.59 | 1.09 | 0.54 to 2.21 |
| Non-preventable cancers | |||||||
| Stomach | 1.00 | 1.03 | 0.81 to 1.31 | 1.70 | 1.48 to 1.96 | 2.26 | 1.50 to 3.40 |
| Liver | 1.00 | 1.10 | 0.84 to 1.44 | 2.31 | 1.99 to 2.68 | 1.63 | 0.98 to 2.70 |
| Pancreas | 1.00 | 0.94 | 0.80 to 1.11 | 1.76 | 1.61 to 1.92 | 1.65 | 1.23 to 2.22 |
| Ovary | 1.00 | 0.99 | 0.86 to 1.14 | 1.56 | 1.44 to 1.69 | 1.13 | 0.82 to 1.56 |
| Kidney | 1.00 | 1.21 | 0.93 to 1.57 | 2.04 | 1.76 to 2.35 | 3.33 | 2.28 to 4.87 |
| Eye, nervous system | 1.00 | 0.79 | 0.64 to 0.98 | 1.61 | 1.43 to 1.80 | 1.39 | 0.89 to 2.18 |
| Non-Hodgkin | 1.00 | 0.99 | 0.76 to 1.29 | 1.96 | 1.70 to 2.25 | 1.54 | 0.95 to 2.52 |
| Multiple myeloma | 1.00 | 0.93 | 0.65 to 1.34 | 2.33 | 1.96 to 2.77 | 1.32 | 0.65 to 2.69 |
| Leukaemia | 1.00 | 0.75 | 0.57 to 0.97 | 1.66 | 1.46 to 1.88 | 1.35 | 0.85 to 2.15 |
Reference category is employed.
All analyses are adjusted for current age, region, migrant background, educational attainment and housing conditions.
Absolute site-specific cancer mortality rates (and 95% CI) (2001–2011) among the Belgian employed population, by occupational group in 1991
| Men | Managers and professionals | Intermediate white-collar | Service and sales workers | Agricultural and fishery workers | Skilled manual workers | Unskilled manual workers |
| All cancers | 163.3 (159.8 to 166.9) | 190.0 (185.9 to 194.1) | 232.3 (221.6 to 242.9) | 177.6 (166.5 to 188.7) | 228.4 (224.0 to 232.8) | 246.3 (238.1 to 254.4) |
| Preventable cancers | ||||||
| Head and neck | 8.2 (7.4 to 9.0) | 10.1 (9.2 to 11.0) | 14.7 (12.1 to 17.3) | 9.8 (6.9 to 12.8) | 12.4 (11.4 to 13.3) | 17.0 (14.9 to 19.1) |
| Oesophagus | 7.6 (6.9 to 8.4) | 8.5 (7.6 to 9.3) | 9.3 (7.2 to 11.4) | 6.4 (4.2 to 8.7) | 9.4 (8.5 to 10.3) | 10.2 (8.5 to 11.8) |
| Stomach | 5.2 (4.6 to 5.8) | 6.2 (5.4 to 6.9) | 5.4 (3.8 to 7.1) | 6.1 (4.1 to 8.1) | 7.9 (7.1 to 8.7) | 8.3 (6.8 to 9.9) |
| Colorectal | 17.5 (16.4 to 18.6) | 19.0 (17.7 to 20.3) | 21.2 (17.9 to 24.4) | 13.6 (10.6 to 16.5) | 20.5 (19.1 to 21.8) | 20.3 (17.9 to 22.7) |
| Liver | 6.3 (5.6 to 7.0) | 6.0 (5.2 to 6.7) | 6.7 (4.9 to 8.5) | 2.0 (0.8 to 3.2) | 5.5 (4.8 to 6.2) | 7.0 (5.7 to 8.4) |
| Lung | 48.0 (46.1 to 49.9) | 62.8 (60.5 to 65.2) | 84.8 (78.4 to 91.3) | 65.1 (58.4 to 71.9) | 91.1 (88.3 to 93.8) | 97.1 (91.9 to 102.2) |
| Prostate | 9.6 (8.8 to 10.4) | 10.2 (9.2 to 11.2) | 11.5 (9.0 to 13.9) | 9.5 (7.3 to 11.7) | 10.6 (9.6 to 11.7) | 11.4 (9.5 to 13.2) |
| Bladder | 4.7 (4.1 to 5.3) | 5.8 (5.1 to 6.6) | 7.0 (5.1 to 8.9) | 4.0 (2.4 to 5.5) | 6.0 (5.3 to 6.7) | 8.2 (6.6 to 9.7) |
| Malignant melanoma | 2.9 (2.4 to 3.4) | 2.7 (2.2 to 3.2) | 3.8 (2.4 to 5.1) | 3.0 (1.4 to 4.6) | 2.4 (2.0 to 2.8) | 2.2 (1.4 to 2.9) |
| Non-preventable cancers | ||||||
| Pancreas | 10.7 (9.8 to 11.6) | 10.2 (9.2 to 11.2) | 11.6 (9.2 to 14.0) | 10.3 (7.5 to 13.0) | 10.1 (9.1 to 11.0) | 11.0 (9.3 to 12.8) |
| Kidney | 5.5 (4.9 to 6.2) | 6.2 (5.5 to 7.0) | 6.0 (4.3 to 7.7) | 5.4 (3.6 to 7.3) | 6.0 (5.3 to 6.7) | 5.4 (4.2 to 6.6) |
| Eye, nervous system | 6.5 (5.8 to 7.3) | 6.8 (6.0 to 7.5) | 6.9 (5.1 to 8.7) | 5.3 (3.3 to 7.3) | 6.2 (5.5 to 6.9) | 6.0 (4.7 to 7.2) |
| Non-Hodgkin | 4.6 (4.0 to 5.1) | 4.5 (3.9 to 5.1) | 5.3 (3.7 to 6.9) | 6.7 (4.4 to 9.0) | 4.8 (4.2 to 5.5) | 3.5 (2.5 to 4.5) |
| Multiple myeloma | 2.5 (2.1 to 3.0) | 3.0 (2.5 to 3.5) | 2.5 (1.3 to 3.6) | 3.4 (1.9 to 4.9) | 2.6 (2.1 to 3.0) | 3.1 (2.2 to 4.0) |
| Leukaemia | 4.9 (4.3 to 5.5) | 5.2 (4.5 to 5.9) | 6.7 (4.9 to 8.5) | 6.0 (4.1 to 7.9) | 5.5 (4.8 to 6.2) | 5.7 (4.5 to 7.0) |
| Women | Managers and professionals | Intermediate white-collar | Service and sales workers | Agricultural and fishery workers | Skilled manual workers | Unskilled manual workers |
| Cancer deaths | 98.2 (95.0 to 101.5) | 106.1 (102.7 to 109.6) | 101.9 (97.0 to 106.8) | 92.9 (79.0 to 106.8) | 107.7 (100.2 to 115.1) | 111.1 (106.0 to 116.2) |
| Preventable cancers | ||||||
| Oesophagus | 1.3 (0.9 to 1.6) | 1.7 (1.3 to 2.2) | 2.2 (1.4 to 2.9) | 1.5 (0.0 to 3.2) | 1.2 (0.4 to 2.0) | 1.8 (1.1 to 2.4) |
| Colorectal | 8.3 (7.3 to 9.2) | 9.9 (8.8 to 11.0) | 8.6 (7.2 to 10.0) | 5.6 (2.5 to 8.7) | 11.4 (9.0 to 13.8) | 8.3 (6.9 to 9.6) |
| Lung | 13.5 (12.3 to 14.7) | 16.5 (15.2 to 17.8) | 17.9 (15.9 to 20.0) | 8.6 (4.5 to 12.8) | 17.2 (14.3 to 20.1) | 22.2 (19.9 to 24.5) |
| Breast | 30.3 (28.5 to 32.1) | 32.1 (30.2 to 33.9) | 26.6 (24.1 to 29.1) | 28.9 (20.6 to 37.3) | 30.1 (26.2 to 33.9) | 27.7 (25.1 to 30.3) |
| Cervix | 1.9 (1.4 to 2.3) | 1.8 (1.4 to 2.3) | 2.6 (1.8 to 3.3) | 1.4 (0.0 to 3.1) | 1.9 (0.9 to 2.8) | 3.0 (2.1 to 3.9) |
| Uterus | 2.4 (1.9 to 2.9) | 2.6 (2.0 to 3.1) | 3.3 (2.4 to 4.2) | 1.6 (0.4 to 2.8) | 3.7 (2.1 to 5.2) | 2.0 (1.4 to 2.7) |
| Bladder | 0.8 (0.5 to 1.1) | 0.8 (0.5 to 1.1) | 1.1 (0.6 to 1.6) | 0.5 (0.0 to 1.2) | 0.9 (0.2 to 1.7) | 1.0 (0.5 to 1.5) |
| Malignant melanoma | 1.8 (1.4 to 2.3) | 2.1 (1.6 to 2.6) | 1.7 (1.0 to 2.3) | 3.0 (0.2 to 5.7) | 2.3 (1.3 to 3.4) | 2.3 (1.5 to 3.0) |
| Non-preventable cancers | ||||||
| Stomach | 1.6 (1.2 to 2.0) | 1.8 (1.3 to 2.2) | 1.8 (1.2 to 2.5) | 5.4 (1.8 to 9.0) | 2.2 (1.1 to 3.3) | 3.1 (2.3 to 4.0) |
| Liver | 1.4 (1.0 to 1.8) | 1.5 (1.1 to 1.9) | 1.7 (1.1 to 2.3) | 1.4 (0.0 to 2.9) | 1.5 (0.6 to 2.4) | 2.1 (1.4 to 2.8) |
| Pancreas | 5.5 (4.7 to 6.3) | 5.2 (4.4 to 5.9) | 5.5 (4.4 to 6.7) | 3.1 (1.5 to 4.8) | 4.8 (3.2 to 6.4) | 5.6 (4.5 to 6.8) |
| Ovary | 7.4 (6.5 to 8.3) | 7.2 (6.3 to 8.1) | 7.0 (5.7 to 8.2) | 10.4 (6.0 to 14.9) | 8.5 (6.4 to 10.6) | 8.3 (6.9 to 9.7) |
| Kidney | 1.9 (1.4 to 2.3) | 1.5 (1.1 to 2.0) | 1.8 (1.2 to 2.5) | 1.7 (0.0 to 3.4) | 1.6 (0.7 to 2.5) | 1.5 (1.0 to 2.1) |
| Eye, nervous system | 4.1 (3.4 to 4.8) | 3.5 (2.9 to 4.1) | 3.6 (2.7 to 4.5) | 4.2 (0.8 to 7.5) | 3.3 (2.1 to 4.5) | 4.1 (3.2 to 5.1) |
| Non-Hodgkin | 1.8 (1.3 to 2.2) | 2.2 (1.7 to 2.7) | 1.9 (1.3 to 2.6) | 1.7 (0.0 to 3.5) | 2.8 (1.6 to 4.0) | 2.0 (1.3 to 2.7) |
| Multiple myeloma | 1.2 (0.8 to 1.5) | 1.3 (0.9 to 1.7) | 1.2 (0.7 to 1.7) | 2.6 (0.0 to 5.5) | 1.0 (0.2 to 1.7) | 1.2 (0.6 to 1.7) |
| Leukaemia | 2.4 (1.9 to 2.9) | 2.6 (2.0 to 3.1) | 2.6 (1.8 to 3.4) | 2.9 (0.4 to 5.5) | 3.3 (1.9 to 4.8) | 2.8 (2.0 to 3.7) |
Net relative site-specific cancer mortality inequality (mortality rate ratios and 95% CI) (2001–2011) among the Belgian employed population, by occupational group in 1991
| Men | Managers and professionals | Intermediate white-collar | Service and sales workers | Agricultural and fishery workers | Skilled manual workers | Unskilled manual workers | |||||
| All cancers | 1.00 | 0.93 | 0.91 to 0.96 | 0.95 | 0.91 to 0.99 | 0.93 | 0.88 to 0.97 | 0.9 | 0.87 to 0.93 | 0.94 | 0.90 to 0.97 |
| Preventable cancers | |||||||||||
| Head and neck | 1.00 | 0.92 | 0.82 to 1.04 | 1.03 | 0.86 to 1.23 | 0.67 | 0.52 to 0.88 | 0.83 | 0.73 to 0.95 | 1.13 | 0.98 to 1.32 |
| Oesophagus | 1.00 | 0.9 | 0.80 to 1.01 | 0.84 | 0.68 to 1.04 | 0.66 | 0.50 to 0.87 | 0.83 | 0.73 to 0.95 | 0.87 | 0.73 to 1.04 |
| Stomach | 1.00 | 0.98 | 0.85 to 1.13 | 0.88 | 0.68 to 1.14 | 0.99 | 0.74 to 1.33 | 0.99 | 0.84 to 1.16 | 1.03 | 0.84 to 1.27 |
| Colorectal | 1.00 | 0.89 | 0.82 to 0.97 | 0.8 | 0.69 to 0.93 | 0.8 | 0.68 to 0.94 | 0.79 | 0.72 to 0.86 | 0.83 | 0.73 to 0.94 |
| Liver | 1.00 | 0.73 | 0.63 to 0.84 | 0.54 | 0.41 to 0.72 | 0.24 | 0.15 to 0.39 | 0.56 | 0.48 to 0.65 | 0.64 | 0.52 to 0.79 |
| Lung | 1.00 | 0.97 | 0.93 to 1.02 | 1.04 | 0.97 to 1.12 | 0.98 | 0.90 to 1.07 | 1.07 | 1.02 to 1.12 | 1.05 | 0.99 to 1.12 |
| Prostate | 1.00 | 0.87 | 0.78 to 0.97 | 0.83 | 0.68 to 1.01 | 1.11 | 0.92 to 1.34 | 0.75 | 0.67 to 0.85 | 0.86 | 0.73 to 1.01 |
| Bladder | 1.00 | 0.93 | 0.79 to 1.08 | 0.94 | 0.72 to 1.22 | 0.74 | 0.54 to 1.01 | 0.85 | 0.72 to 1.00 | 1.08 | 0.88 to 1.34 |
| Malignant melanoma | 1.00 | 0.86 | 0.70 to 1.04 | 1.11 | 0.81 to 1.53 | 1.11 | 0.76 to 1.62 | 0.53 | 0.42 to 0.66 | 0.62 | 0.45 to 0.84 |
| Non-preventable cancers | |||||||||||
| Pancreas | 1.00 | 0.88 | 0.79 to 0.98 | 0.84 | 0.69 to 1.01 | 0.94 | 0.76 to 1.15 | 0.74 | 0.66 to 0.83 | 0.78 | 0.67 to 0.92 |
| Kidney | 1.00 | 0.94 | 0.82 to 1.08 | 0.85 | 0.66 to 1.10 | 0.85 | 0.64 to 1.14 | 0.77 | 0.66 to 0.90 | 0.64 | 0.51 to 0.81 |
| Eye, nervous system | 1.00 | 0.93 | 0.81 to 1.06 | 0.87 | 0.69 to 1.11 | 0.93 | 0.70 to 1.23 | 0.7 | 0.61 to 0.82 | 0.7 | 0.56 to 0.87 |
| Non-Hodgkin | 1.00 | 0.85 | 0.73 to 1.00 | 1 | 0.76 to 1.31 | 1.32 | 0.99 to 1.76 | 0.83 | 0.69 to 0.99 | 0.72 | 0.55 to 0.93 |
| Multiple myeloma | 1.00 | 1.09 | 0.90 to 1.34 | 0.69 | 0.44 to 1.07 | 1.55 | 1.09 to 2.22 | 0.82 | 0.65 to 1.04 | 0.9 | 0.65 to 1.25 |
| Leukaemia | 1.00 | 0.95 | 0.81 to 1.11 | 1.13 | 0.87 to 1.47 | 1.33 | 1.01 to 1.74 | 0.9 | 0.76 to 1.07 | 0.95 | 0.75 to 1.20 |
| Women | Managers and professionals | Intermediate white-collar | Service and sales workers | Agricultural and fishery workers | Skilled manual workers | Unskilled manual workers | |||||
| Cancer deaths | 1.00 | 0.89 | 0.86 to 0.93 | 0.79 | 0.75 to 0.83 | 0.91 | 0.82 to 1.02 | 0.77 | 0.72 to 0.82 | 0.83 | 0.79 to 0.88 |
| Preventable cancers | |||||||||||
| Oesophagus | 1.00 | 0.86 | 0.60 to 1.22 | 1.02 | 0.66 to 1.59 | 0.94 | 0.39 to 2.25 | 0.56 | 0.29 to 1.07 | 0.95 | 0.60 to 1.52 |
| Colorectal | 1.00 | 1.00 | 0.88 to 1.15 | 0.84 | 0.70 to 1.01 | 0.66 | 0.43 to 1.01 | 1.04 | 0.85 to 1.29 | 0.86 | 0.71 to 1.03 |
| Lung | 1.00 | 0.89 | 0.80 to 0.99 | 0.82 | 0.72 to 0.94 | 0.48 | 0.33 to 0.70 | 0.78 | 0.66 to 0.92 | 0.86 | 0.75 to 0.98 |
| Breast | 1.00 | 0.93 | 0.86 to 1.00 | 0.74 | 0.67 to 0.82 | 1.03 | 0.84 to 1.27 | 0.75 | 0.66 to 0.85 | 0.75 | 0.67 to 0.84 |
| Cervix | 1.00 | 0.79 | 0.57 to 1.08 | 0.78 | 0.53 to 1.15 | 0.44 | 0.14 to 1.41 | 0.54 | 0.33 to 0.88 | 0.8 | 0.55 to 1.18 |
| Uterus | 1.00 | 0.91 | 0.70 to 1.19 | 1.07 | 0.78 to 1.47 | 0.68 | 0.32 to 1.42 | 0.91 | 0.59 to 1.42 | 0.7 | 0.48 to 1.02 |
| Bladder | 1.00 | 0.93 | 0.59 to 1.47 | 1.68 | 0.95 to 2.98 | 1.69 | 0.57 to 4.97 | 1.61 | 0.81 to 3.22 | 1.48 | 0.78 to 2.81 |
| Malignant melanoma | 1.00 | 1.07 | 0.81 to 1.40 | 0.68 | 0.45 to 1.03 | 0.76 | 0.31 to 1.88 | 0.95 | 0.61 to 1.47 | 1.03 | 0.72 to 1.49 |
| Non-preventable cancers | |||||||||||
| Stomach | 1.00 | 1.03 | 0.76 to 1.41 | 0.9 | 0.61 to 1.35 | 1.68 | 0.87 to 3.21 | 0.87 | 0.52 to 1.43 | 1.67 | 1.16 to 2.40 |
| Liver | 1.00 | 0.78 | 0.56 to 1.10 | 0.64 | 0.41 to 0.99 | 0.27 | 0.06 to 1.14 | 0.71 | 0.40 to 1.24 | 1.07 | 0.72 to 1.59 |
| Pancreas | 1.00 | 0.8 | 0.67 to 0.95 | 0.76 | 0.61 to 0.96 | 0.82 | 0.52 to 1.31 | 0.72 | 0.53 to 0.98 | 0.89 | 0.70 to 1.12 |
| Ovary | 1.00 | 0.76 | 0.65 to 0.88 | 0.79 | 0.64 to 0.96 | 1.63 | 1.20 to 2.21 | 0.82 | 0.64 to 1.04 | 0.79 | 0.64 to 0.97 |
| Kidney | 1.00 | 0.54 | 0.39 to 0.74 | 0.7 | 0.47 to 1.03 | 1.04 | 0.52 to 2.09 | 0.59 | 0.36 to 0.98 | 0.62 | 0.41 to 0.94 |
| Eye, nervous system | 1.00 | 0.73 | 0.59 to 0.90 | 0.8 | 0.62 to 1.05 | 1.16 | 0.69 to 1.95 | 0.71 | 0.50 to 1.00 | 0.72 | 0.53 to 0.97 |
| Non-Hodgkin | 1.00 | 1.01 | 0.75 to 1.35 | 0.78 | 0.53 to 1.15 | 1.33 | 0.69 to 2.59 | 1.09 | 0.69 to 1.72 | 0.82 | 0.56 to 1.21 |
| Multiple myeloma | 1.00 | 0.98 | 0.70 to 1.38 | 0.91 | 0.57 to 1.45 | 0.77 | 0.27 to 2.17 | 0.71 | 0.35 to 1.43 | 0.8 | 0.49 to 1.30 |
| Leukaemia | 1.00 | 0.87 | 0.68 to 1.12 | 0.75 | 0.53 to 1.07 | 0.89 | 0.47 to 1.69 | 0.77 | 0.51 to 1.18 | 0.89 | 0.64 to 1.24 |
Reference category is managers and professionals.
All analyses are adjusted for current age, region, migrant background, educational attainment and housing conditions.